CODA Biotherapeutics
CODA Biotherapeutics is a preclinical-stage biopharmaceutical company.
Launch date
Market cap
-
Enterprise valuation
$112—168m (Dealroom.co estimates Dec 2021.)
South San Francisco California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
$19.0m | Series A | ||
$15.0m | Series A | ||
* | $28.0m | Series A | |
| Total Funding | $62.0m | ||
